The synthesis, characterization and biomedical applications of mixed metal oxide is receiving increasing interest due to their property related specific applications.In this regard, ZnO and Ag 2 O have been applied for different biomedical applications individually but the effect of Ag 2 O on cell viability of ZnO has not been reported yet. The objective of this study is to see the effect of Ag 2 O nanoparticle on cell viability of ZnO nanoparticles synthesized by adopting a two-step low temperature solution process. X-ray diffraction study confirms the co-existence of ZnO and Ag 2 O phases. Transmittance electron microscopy has been used to characterize the morphological properties of the samples. X-ray photoelectron spectroscopic analysis also confirms the formation of ZnO-Ag 2 O nanocomposite. The in vitro cytotoxicity with the help of MTT assay (upto a maximum of 200 μg/mL) on HeLa cell line approves thatthe ZnO-Ag 2 O (ZSO) nanocomposite is more biocompatible than the individual ZnO and Ag 2 O nanoparticle. This nanocomposite ZSO can be used as a vehicle for drug delivery systems.
INTRODUCTION
Nanocomposites with mixed oxides have received growing interest due to their various applications in different biomedical applications like drug delivery, bioimaging, biosensing, antibacterial activity etc. [1] . The basic advantage of the mixed oxide is that the properties of the individual oxides can be tuned for a better functional nanocomposite whose activity would be much more effective than individual oxide. Most mixed oxides show the combined property of the individual oxides due to their interaction between constituent materials. Mixed metal oxide such as Fe 3 O 4 -Ag 2 O [2] , CuO-ZnO [ 3] , CuO-NiO [ 4] , Fe 3 O 4 -ZnO [5] has already been reported for different biomedical applications due to their showing of combined properties. In recent years, nanosized ZnO and Ag 2 O have been extensively used for numerous biomedical applications like antibacterial activity, anticancer activity, bioimaging, drug delivery etc. due to their unique physical and chemical properties [1, [6] [7] . Therefore, it is not hard to detect the numerous reports on the biocompatibility of ZnO nanoparticle before its use for in vivo applications in cell systems regarding drug delivery and bioimaging studies. Ag 2 O is a p-type semiconductor and has mainly been used for antibacterial, anti-parasitic and photocatalytic activity [2] . Despite their advantageous properties regarding biomedical applications, no other study has shown the effect of Ag 2 O on ZnO nanoparticle regarding biocompatibility. Therefore, developing a new mixed metal oxide nanocomposite combining ZnO and Ag 2 O can give a new direction for different biomedical applications. In this respect, Fakhri et al. [2] showed that Fe 3 O 4 -Ag 2 O quantum dots decorated cellulose nanofibers which can be used as a carrier of anticancer drugs for skin cancer. But, to the best of our knowledge, no other study has shown the cytotoxicity nature of ZnO-Ag 2 O nanocomposite. Therefore, in this present work, the effect of Ag 2 O on cell viability of ZnO nanoparticle synthesized by low temperature solution synthesis has been explored. Two-step synthesis processes have been used to synthesize ZnO-Ag 2 O nanocomposite. Then the synthesized samples were used for materials characterizations and systematic cell viability study on HeLa cell line. The cell viability result of the ZnO-Ag 2 O nanocomposite showed admirable biocompatibility even in higher concentration which can be useful as a drug delivery vehicle for future applications.
MATERIALS AND METHODS

Synthesis of ZnO nanoparticles (ZO).
ZnO nanoparticles (ZO) were synthesized by a facile low temperature solution synthesis process. Initially, 50 mmol zinc chloride [(ZnCl₂, Junsei Chemical Co. Ltd ≥ 98%] solution was prepared in 200 mL of deionized water. Then, NH 4 OH (Junsei Chemical Co. Ltd, 28-30%) was added under continuous stirring to the zinc chloride solution until the pH of the medium reached to 10. After that, the solution was kept stirring at a constant temperature for 3h at 90°C. Then, the solid materials were washed with deionized water and ethanol by centrifugation process for 3 -4 times. Finally, the samples were dried in an air oven at ~60 o C for 24 h duration.
Synthesis of ZnO-Ag 2 O (ZSO) nanocomposite.
The synthesis of ZSO nanocomposite was made by using synthesized ZO nanoparticles, AgNO 3 (Junsei Chemical Co. Ltd), PEG-8000 (Sigma Aldrich)and NaOH. Initially, 0.4 g ZO nanoparticles and 2 g of PEG-8000 were uniformly dispersed in 100 mL of deionized water through a continuous stirring. Then 1.8 g of AgNO 3 was added to the mixture and stirred continuously for 30 minutes. After that, 0.2 M NaOH solution was added into the mixture dropwise for pH to reach 14 with continuous stirring. Next, the precipitate was separated out by centrifugation and product, ZSO was initially washed with deionized water followed by ethanol for 3-4 times. Finally, the product was dried in an air oven at ~60 o C for 24 h. The similar process was followed for the synthesis of Ag 2 O (SO) nanoparticles [8] without the addition of ZO nanoaprticles.
Materials properties.
X-ray diffractometer (Philips PW3050 X-ray diffraction unit) with nickel filtered CuK α radiation source (λ =1.54060 Å) was used to obtain the X-ray diffraction (XRD) patterns of the samples (2 range, 5 o -80 o ). Transmission electron-/-high resolution transmission electron microscopy (TEM/HRTEM) measurements were performed by JEOL make (JEM-2010, Japan) instrument at an accelerating voltage of 200 kV. Carbon coated Cu grids were used for sample placement in this measurement. The samples were carefully placed onto separate Cu-grids after the dispersion in methanol by ultrasonication. X-ray photoelectron spectrum (XPS) with binding energy range, 200 -1200 eV for ZSO was recorded to decide the chemical state of elements and chemical interaction/complexation of rGO with the inorganic moiety present in the sample by employing Theta Probe (Thermo Fisher Scientific Inc., USA) XPS microprobe surface analysis system.
Cytotoxicity study.
The cytotoxicity of ZO, SO and ZSO samples was measured using HeLa cell line procured from ATCC, USA. Dulbecco's modified eagles medium (DMEM, Gibco, USA), fetal bovine serum (FBS, Gibco, USA), PenStrep (Gibco, USA) and MTT (3-[4,5dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide, Sigma, USA) were used as essential chemicals and reagents for the study.
Measurement of in vitro cellular cytotoxicity by MTT assay.
HeLa cell line was cultured in DMEM (Gibco) supplemented with 10% fetal bovine serum (FBS) and antibiotic (1% penicillin/streptomycin) in 5% CO 2 at 37 o C. MTT assay was used to measure the cellular toxicity. Initially, HeLa cells (10 4 cells per well) were seeded on to a flat bottom 96-well plate and incubated at 37 o C in 5% CO 2 one day before the treatment. Then the cells were treated with or without (i.e. vehicle control) nanocomposite at different concentrations, ranging from 0 to 200 μg/mL and kept for 24 h. Later, it was subjected to MTT assay. 100 μL of DMEM solution containing 10 μL of MTT (5 mg/mL) was added to each well. After 4 h of incubation, the media was removed and cells were dispersed in 100 μL of 1:1 (v/v) solvent mixture of dimethyl sulphoxide (DMSO) and Methanol. Absorbance spectra of the samples were measured at 570 nm wavelength by SpectraMax M5e Multi-Mode Microplate Reader. The cell viability values were expressed in percentages with respect to control values.
RESULTS
Materials properties of nanocomposites.
3.1.1. Phase structure.X-ray diffraction study ( Fig. 1) Figure 2a , 2b. The corresponding HRTEM of the sample is also shown in Figure 2c . It is evident from Figure 2c that distinct lattice fringes with an interplanar spacing of 0.28 nm can be found which can be indexed to (100) crystal plane of ZnO (ZO) [7] . Moreover, another lattice fringes with an interplanar spacing of 0.23 nm can also be found which corresponds to (200) the coexistence of ZnO and Ag 2 O crystal phase structure of the ZSO sample can be confirmed the TEM result and fully corroborated with the XRD (Fig. 1 ) of the sample. Furthermore, Figure 2d shows the selected area electron diffraction (SAED) pattern of ZSO sample to confirm the coexistence of ZnO and Ag 2 O crystal phase. The (101), (102) crystal planes of ZnO and (111), (220) crystal planes of Ag 2 O can be clearly distinguishable from the rings present in Figure 2d . The TEM microstructure of ZSO sample confirms the formation of nanocomposite with ZnO and Ag 2 O nanoparticle. 3.1.3 XPS analysis. Figure 3 shows the XPS data of the representative sample ZSO to understand the surface chemical composition and the valence state of the elements. The binding energy signals of Zn2p and Ag3d are shown in Figure 3a and 3b, respectively. As can be seen from the Figure 3a , two peaks at ~1022.1 eV and ~1045.2 eV can be seen for the binding energy signals of Zn 2p which can be assigned to the binding energy of Zn 2p 3/2 and Zn 2p 1/2 , respectively [6, 10] . The energy difference between Zn 2p 3/2 and Zn 2p 1/2 binding energy levels is ~ 23.1 eV. The energy difference level is also the confirmation of the oxidation state of Zn ions which is II [6, 11] . Moreover, the existence of Ag3d is also assessed and shown in Figure 3b . The peaks are found at ~367.4 eV and ~373.4 eV (Fig. 3b) can be assigned to Ag3d 5/2 and Ag3d 3/2 , respectively and also the characteristic peaks of Ag + for Ag 2 O in ZSO nanocomposite [8, 12] . Therefore, the XPS result is well supported the XRD data and confirmed the formation of ZnO-Ag 2 O (ZSO) nanocomposite. 
In vitro cellar cytotoxicity .
MTT assay was performed on HeLa ( Fig. 4) 
CONCLUSIONS
In conclusion, we can say that the zinc oxide (ZnO) -silver oxide (Ag 2 O) nanocomposite (ZSO) has been successfully synthesized by adopting two-step low temperature solution process. X-ray diffraction study, transmittance electron microscopy and X-ray photoelectron spectroscopic analysis were effectively used to confirm the formation of ZnO-Ag 2 O nanocomposite. The MTT assay on HeLa cell line showed that the Ag 2 O nanoparticle does not affect the biocompatibility of ZnO nanoparticles and can be used as a vehicle for drug delivery systems. 
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